Geode Capital Management »

Prelude Therapeutics shares owned by Geode Capital Management

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.7M 362k 4.74
2023-09-30 $1.0M 331k 3.09
2023-06-30 $1.1M 242k 4.50
2023-03-31 $832k 146k 5.70
2022-12-31 $873k 145k 6.03
2022-09-30 $1.0M 153k 6.60
2022-06-30 $708k 136k 5.22
2022-03-31 $1.4M 208k 6.90
2021-12-31 $2.6M 213k 12.45
2021-09-30 $7.8M 249k 31.25
2021-06-30 $6.4M 223k 28.63
2021-03-31 $8.6M 199k 43.33
2020-12-31 $14M 192k 71.54